Showing posts with label FDA Approves Imbruvica (ibrutinib) Plus Obinutuzumab as First Non-Chemotherapy Combination. Show all posts
Showing posts with label FDA Approves Imbruvica (ibrutinib) Plus Obinutuzumab as First Non-Chemotherapy Combination. Show all posts
Saturday, February 9, 2019

FDA Approves Imbruvica (ibrutinib) Plus Obinutuzumab as First Non-Chemotherapy Combination Regimen for Treatment-Naïve Patients with Chronic Lymphocytic Leukemia

›
In continuation of my update on    ibrutinib The Janssen Pharmaceutical Companies of Johnson & Johnson announced  the U.S. Foo...